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The gut microbiome contributes to the development
and function of the immune, metabolic, and nervous
systems. Furthermore, commensal bacteria modulate
symptoms and pathology in mouse models of
neuropsychiatric and neurodevelopmental diseases.
Uncovering mechanisms that are utilized by the
microbiome to mediate gut–brain connections may
provide novel opportunities to target therapies to the
gut in order to treat neurologic disorders.antibiotics have a greater risk of developing behavioralThe gut microbiome and brain disorders
Disorders of the brain such as anxiety, depression, epi-
lepsy, and autism spectrum disorder (ASD) have been
linked to the gut microbiome, largely in preclinical
models [1]. Microbiome changes in humans have been
cataloged in many neurologic conditions, and mouse
models have revealed that gut microbes contribute to
disease progression and severity of symptoms [1]. Recent
work in this area reports new findings in disorders of
the brain and in well-established murine models of be-
havior [2–5]. These studies indicate that a combination
of factors, including prenatal environments, diet, and
host genetics, impact the fitness of an individual’s micro-
biome. Changes to host microbiome composition coin-
cide with neurologic changes affecting behavior,
neurotransmitter levels, stress response, and gene ex-
pression in the brain [2–5]. These findings highlight a
growing appreciation that gut bacteria may contribute to
neuropsychiatric disorders, and potentially reveal attract-
ive targets for translational studies in humans.Early-life influences
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colonizers are instrumental during development in edu-
cating the immune system, metabolizing nutrients, and
influencing complex behaviors. One example of the im-
pact of early colonization is illustrated by differences in
cognitive scores between infants born via cesarean sec-
tion and vaginally born children [6]. The lower scores of
children born via cesarean section may result from dif-
ferences in early gut colonization by microbes from the
mother’s skin (caesarean) or vagina (natural birth), re-
spectively [6]. Infants who have increased exposure to
symptoms such as depression [1]. Further evidence of
early-life influences comes from observations that for-
mula feeding, which alters the microbiome, may be a
risk factor for ASD [7], although considerable additional
work in humans is needed to establish causality.
Prenatal stress can also affect microbiome composition
after birth and is linked to increased risk of developmental
disorders of the brain [2]. Stress induces distinct changes
in the vaginal microbiome composition, so mothers who
are under stress may transmit an imbalanced bacterial
community to their offspring [2]. Stress responses can be
measured by activation of the hypothalamic-
pituitary-adrenal (HPA) axis, which is one of the major
routes of communication between the periphery and the
brain. Male mouse pups born to stress-exposed dams ex-
hibit increased stress, indicated by elevated levels of cor-
ticosterone in the serum and altered gene expression in the
hypothalamus [2]. It is difficult to determine whether this
phenotype results from prenatal effects or microbial
colonization at birth. Jašarević et al. [2] showed that
colonization of mice with untreated, control vaginal micro-
biota normalized, albeit partially, features such as body
weight and corticosterone levels following acute stress in
male offspring. The fact that these negative effects could
not be reversed fully suggests that stress also affects the
mouse pups before birth (i.e., prior to microbiome expos-
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sion of genes implicated in innate immunity and inflamma-
tion based on prenatal stress-exposure in males [2].
Therefore, it is likely that environmental risk factors, such
as prenatal stress, alter the intestinal niche of the fetus be-
fore microbes even colonize the gut and could select
against beneficial microbes.
In theory, reduced prenatal stress should promote
microbiome health and normal immune system develop-
ment. When early-life perturbations such as cesarean
section or treatment with antibiotics contribute to symp-
toms, colonizing newborns with missing or depleted mi-
crobes or with a complex microbiome from a verified
healthy donor may provide benefits [8].
Diet-induced changes
Although the initial colonization of the gut plays a crit-
ical role in shaping the microbiome, diet has a signifi-
cant impact on microbial composition throughout life
[1, 3]. A high-fat diet (HFD) can result in obesity by in-
ducing gut dysbiosis [3]. Although obesity and diabetes
are not traditionally considered neurologic disorders,
they often co-occur with anxiety and depression [3].
Diet-induced obesity (DIO) mice fed an HFD exhibit
hallmark characteristics of diabetes, including insulin re-
sistance and hyperglycemia, and also display behaviors
symptomatic of anxiety and depression [3]. Soto et al.
[3] found that DIO mice display abnormal neurotrans-
mitter levels including increases in brain levels of
γ-aminobutyric acid (GABA) and tryptophan, a precur-
sor of serotonin, which are associated with mood and
behavior in humans. Antibiotic treatment with vanco-
mycin and metronidazole depletes Gram-positive and
Gram-negative anaerobic bacteria in the gut, respect-
ively. Both antibiotic treatments ameliorated the behav-
ioral deficits and diabetes-like symptoms found in DIO
mice. This evidence indicates that an HFD may enrich
populations of gut microbes that play a role in the physi-
ology of obesity and diabetes, and suggests that treat-
ments that eliminate certain microbes may help treat
both metabolic and behavioral conditions [3].
Conversely, some diets have therapeutic potential for
neurologic disorders. The ketogenic diet (KD) consists
of high fat content foods but minimal amounts of carbo-
hydrates, which causes metabolism of fat instead of car-
bohydrates for energy. The KD has been used to treat
epilepsy for a century, but the importance of the gut
microbiome in mediating this effect was largely un-
known [4]. Olson et al. [4] found that administration of
the KD to a mouse model of epilepsy that uses electrical
stimulation to induce seizures (6-Hz seizure mouse
model) resulted in changes in the microbiome compos-
ition and made the mice more resistant to seizures. The
microbiome is necessary for the beneficial effects of thediet, as antibiotic-treated and germ-free mice fed the KD
do not reap the protective effects of the diet. KD-fed mice
are enriched in the bacteria Akkermansia muciniphila,
Parabacteroides merdae, and Parabacteroides distasonis,
which were shown to be involved in promoting the diet’s
anti-seizure effects. Manipulation of the gut microbiome
through the KD or colonization with A. mucinophilia and
Parabacteroides provided protective benefits against sei-
zures by altering brain neurotransmitter levels, including
GABA and glutamate in the hippocampus [4]. GABA is
the major inhibitory neurotransmitter in the brain, and re-
duced levels are known to exacerbate seizures. Diet is thus
an effective means of manipulating neurotransmitter
levels in the brain, with the resulting diet–microbiome in-
teractions mediating the effects of seizures.Genetic interactions
Studies have begun to use DNA sequencing to investi-
gate the impact of host genetics on the microbiome and
to look at how gene–environment interactions affect
neurological disease [9]. Whole-genome association
studies have revealed genetic variants involved in host
immunity and metabolism that may predispose individ-
uals to gut dysbiosis [9]. Genetic mutations that are as-
sociated with neurological disorders may also alter the
host intestinal niche and perturb the microbiome.
ASD is a complex neurological disorder with diverse
genetic and environmental etiologies [5]. Children with
ASD are at least three times more likely to experience
chronic gastrointestinal symptoms than neurotypical chil-
dren, suggesting that ASD physiology is linked to gut dys-
biosis [10]. Accordingly, a number of studies have shown
that the microbiome is altered in children with ASD com-
pared with controls [5]. Many genetic variants associated
with ASD involve synaptic transmission [5]. A mutation
affecting SHANK3, a scaffolding protein in the postsynap-
tic density of excitatory neurons, contributes to about 2%
of ASD cases in humans [5]. A mouse line with homozy-
gous knockout of Shank3 exhibited repetitive behaviors
and abnormal social interactions, which are characteristic
features of human ASD. Tabouy et al. [5] showed that
Shank3−/− mice have reduced gut microbiome diversity,
with diminished populations of certain species of bacteria,
such as Lactobacillus reuteri, Lactobacillus brevis, and
Lactobacillus ruminis. Gut colonization with L. reuteri im-
proved behavioral outcomes in male mice and increased
the expression of GABA receptors in the brain [5]. This
finding is consistent with the abnormal excitatory and in-
hibitory synaptic transmission through glutamate and
GABA signaling reported in ASD [11]. It appears that en-
richment of (or treatment with) specific commensal mi-
crobes may be a promising avenue for ameliorating
certain behavioral disorders.
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At present, genetic and environmental factors (and their
effect on the microbiome) are investigated separately.
The effects of genetic predispositions on neurological
disorders are compounded by diet choices, prescription
medications, exercise, age, and life experiences, all of
which shape the microbiome [2]. Studying these compo-
nents individually ignores critical interactions between
various factors, thus limiting our understanding of the
complex mechanisms linking gut dysbiosis and neuro-
logic conditions. Preclinical models that can rigorously
control for and test genetic and environmental factors
will serve as useful representations of the diverse influ-
ences that impact neurologic function, including the
microbiome. Animal models provide opportunities to
discover therapeutic options, such as microbiota trans-
plants and potential dietary interventions, that can be in-
dividually tailored for distinct neuropsychiatric and
neurodevelopmental disorders. Microbiome-based treat-
ments aimed at influencing neurological responses, such
as neurotransmitter release, stress responses, and neuro-
logical development, could be designed in accordance
with an individual’s genetic risk for a given disease. As it
remains challenging to correct genetic predispositions,
the correction of altered microbiomes appears to be a
more viable approach toward novel therapeutics for
neurologic disorders.
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